N-(4-Tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: I. In Vitro Characterization and Pharmacokinetic Properties-Reference-Cited by-同舟云学术

N-(4-Tertiarybutylphenyl)-4-(3-chloropyridin-2-yl)tetrahydropyrazine -1(2H)-carbox-amide (BCTC), a Novel, Orally Effective Vanilloid Receptor 1 Antagonist with Analgesic Properties: I. In Vitro Characterization and Pharmacokinetic Properties

Published:2003-04-29 Issue:1 Volume:306 Page:377-386
ISSN:0022-3565
Container-title:Journal of Pharmacology and Experimental Therapeutics
language:en
Short-container-title:J Pharmacol Exp Ther

Author:

Valenzano Kenneth J.,Grant Elfrida R.,Wu Gang,Hachicha Mohamed,Schmid Lori,Tafesse Laykea,Sun Qun,Rotshteyn Yakov,Francis Joseph,Limberis James,Malik Shiazah,Whittemore Edward R.,Hodges Dianne

Publisher

American Society for Pharmacology & Experimental Therapeutics (ASPET)

Subject

Pharmacology,Molecular Medicine

Reference41 articles.

1. Extracellular Protons Both Increase the Activity and Reduce the Conductance of Capsaicin- Gated Channels

2. Vanilloid and TRP channels: a family of lipid-gated cation channels

3. Protons activate a cation conductance in a sub-population of rat dorsal root ganglion neurones.

Cited by 190 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current insights and therapeutic strategies for targeting TRPV1 in neuropathic pain management;Life Sciences;2024-10

2. Human heat sensation: A randomized crossover trial;Science Advances;2024-09-06

3. TRPV1 channel in the pathophysiology of epilepsy and its potential as a molecular target for the development of new antiseizure drug candidates;Progress in Neurobiology;2024-09

4. Focused magnetic stimulation for motor recovery after stroke;Brain Stimulation;2024-09

5. Contribution of transient receptor potential vanilloid 1 (TRPV1) channel to cholinergic contraction of rat bladder smooth muscle;The Journal of Physiology;2024-07-06